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Impact of Bariatric Surgery on Carotid Artery Inflammation
and the Metabolic Activity in Different Adipose Tissues
Jan Bucerius, MD, Guy H.E.J. Vijgen, MD, PhD, Boudewijn Brans, MD, PhD,
Nicole D. Bouvy, MD, PhD, Matthias Bauwens, PhD, James H.F. Rudd, MD, PhD,
Bas Havekes, MD, PhD, Zahi A. Fayad, PhD, Wouter D. van Marken Lichtenbelt, PhD,
and Felix M. Mottaghy, MD
Abstract: In this study, we unravel a molecular imaging marker
correlated with the known reduction of cardiovascular events (most
commonly related to vulnerable plaques) in morbidly obese patients
after bariatric surgery (BaS).
We prospectively imaged 10 morbidly obese subjects with
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/com-
puted tomography before and 1 year after BaS. 18F-FDG uptake—which is
enhanced in inflamed, atherosclerotic vessels and in metabolically active
adipose tissues—was quantified in the carotids, pericardial adipose tissue
(PAT), visceral adipose tissue (VAT), as well as brown adipose tissue
(BAT). The degree of carotid inflammation was compared to lean and
overweight controls.
Carotid inflammation significantly declined leading to an 18F-FDG
uptake comparable to the 2 control groups. Metabolic activity signifi-
cantly decreased in PAT and VAT and increased in BAT.
BaS leads to a normalization of carotid artery inflammation and a
beneficial impact on the metabolic activity in PAT, VAT, and BAT that is
related to the metabolic syndrome observed in this patient group.
(Medicine 94(20):e725)
Abbreviation: 18F-FDG = 18F-fluorodeoxyglucose, BaS =
bariatric surgery, BAT = brown adipose tissue, PAT = pericardial
adipose tissue, SAT = subcutaneous adipose tissue, VAT = visceral
adipose tissue.
INTRODUCTION
M ost epidemiological studies demonstrate that obesity isassociated with increased cardiovascular morbidity and
mortality.1,2 Unfortunately,>80% of even highly motivated obese
patients are unable to achieve weight loss with dietary or lifestyle
modifications alone.3,4 Furthermore, medical treatment with anti-
obesity drugs has shown either no effect on primary cardiovas-
cular end points or even an increased risk of nonfatal myocardial
infarction or stroke.4–6 In contrast, several studies such as the
Swedish obese subjects (SOS) trial revealed an association
between bariatric surgery (BaS)-induced weight loss and a
reduced number of cardiovascular events.2,5,7,8 However, there
is a lack of data about a potential direct impact of BaS on
atherosclerotic changes in morbidly obese patients. In contrast,
it is well known that the link between adipose tissue and vascular
integrity, with proinflammatory changes in fat tissue, is related to
vascular endothelial dysfunction.9 This might at least partly
explain the beneficial effects of BaS on cardiovascular events.9
Supporting this pathophysiologic link, it became evident that
expansion of abdominal visceral adipose tissue (VAT) and peri-
cardial adipose tissue (PAT) associates with the metabolic syn-
drome and incident cardiovascular disease, mainly coronary artery
disease and vascular calcification.10–12 Additionally, recent work
has better described the role and distribution of different types of
fat. Human brown adipose tissue (BAT) is of special interest as it
is known to be metabolically active by producing heat (thermo-
genesis) in response to cold conditions, which leads to enhanced
energy expenditure and weight loss, with increased glucose and
fatty acid uptake in BAT.13–15 Accordingly, obese and overweight
subjects were shown to have lower BAT activity.13,15,16 Thus,
BAT has emerged as a potential target for the treatment of obesity
and obesity-associated cardiovascular diseases. However, whether
BAT has a direct effect on vessel biology is not yet known.16
18F-fluorodeoxyglucose (18F-FDG) positron emission
tomography (PET) reflects the metabolic rate of glucose, a
process known to be enhanced in inflamed vascular tissue.
Accordingly, 18F-FDG uptake was shown to be significantly
associated with the degree of macrophage infiltration in vas-
cular plaques.17,18 Furthermore, 18F-FDG PET demonstrated
the presence of BAT in adult humans localized to areas close to
the clavicles, axilla, aorta, cervical, vertebra, as well as the
suprarenal regions and also seems to serve as a surrogate marker
for increased metabolic activity in PAT and VAT.14,15,19–21
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In this study, the 18F-FDG PET technique was used to
evaluate changes of the degree of carotid artery inflammation
and the metabolic activity in PAT, VAT, and BAT in morbidly
obese patients as depicted by 18F-FDG-PET 1 year after BaS.
METHODS
Study Design
The study was conducted at the Maastricht University
Medical Center (MUMCþ), Maastricht, The Netherlands. All
subjects gave written informed consent. The study was
approved by the institutional review board and was performed
according to the STROBE guidelines for cohort, case–control,
and cross-sectional studies.22
All morbidly obese patients who presented at MUMCþ for
planning of BaS were consecutively screened for inclusion in
the study. Based on strict inclusion criteria, 2 male and 8 female
patients, with a mean body mass index (BMI, kg/m2) of
41.7 4.34 were included in the study.20 Exclusion criteria
were known cardiovascular disease and risk factors for it,
including hypertension, nicotine abuse, diabetes mellitus,
and/or the use of statins or b-blockers, of which the latter is
known to significantly reduce the metabolic activity of BAT. To
exclude any impact of medication on vascular and fat tissue 18F-
FDG uptake, only patients without any change in their medi-
cations after BaS were further analyzed. However, none of the
patients, except 1 patient requiring thyroid hormone substitution
therapy, received any kind of medication throughout the study
period. Most importantly, none of the patients received any kind
of anti-inflammatory medication, either before or after BaS.
18F-FDG PET/computed tomography (CT) data of lean (BMI
< 25) or overweight (BMI  25 < 30) healthy people, who
participated in a previous study on BAT assessment, were
reanalyzed in order to serve as controls for the vascular analyses
in the morbidly obese patients.15 Accordingly, data of people
with BMI values 30 were excluded from serving as controls.
As with the morbidly patients, none of the subject in the control
groups suffered from cardiovascular disease or diabetes was




As earlier described in detail, a cooling protocol was
applied to assure a standardized thermal situation for all
included subjects.15,19,20 In short, 1 hour of measuring under
thermoneutral conditions (room temperature before weight loss:
22.8 0.68C, after weight loss: 23.7 0.98C; time (t)0–t60)
was followed by 2 hours of individual mild cold (t60–t180). At
the end of the first hour of cooling (t120), 18F-FDG was
injected. After the second hour of cooling, 18F-FDG PET/CT
imaging (Gemini TF PET/CT; Philips Healthcare Nederland
B.V., Eindhoven, The Netherlands) was performed to quantify
metabolically active BAT.
The PET/CT scanning protocol included confirmation of
the serum glucose level (5.13–5.19 mmol/L) and the intrave-
nous injection of a mean standard dose of 78.1–83.4 MBq
(2.11–2.25 mCi) 18F-FDG (Table 1). A low-dose noncon-
trast-enhanced CT scan (30 mAs) was performed for attenuation
correction and localization of the 18F-FDG uptake sites,
immediately followed by the PET scan.15 Total radiation dose
from the PET/CT scan was approximately 2.8 mSv.
PET Image Analyses
An experienced reader (J.B.) who was blinded to the
patient’s characteristics and the date of the scan (presurgical
or postsurgical 18F-FDG PET/CT) analyzed all scans. Method-
ology for analysis and reproducibility of the measurements have
been previously reported in part.23,24
Image Analysis of BAT
Methodology for BAT analysis has been previously
reported.15,19,20 In short, BAT activity measured as the maximal
standardized uptake value (SUVmax) was quantified in the
region of interest (ROI) in the BAT areas with a set threshold
(SUVmax  1.0). The SUV is the decay-corrected tissue con-
centration of 18F-FDG in kBq/mL, adjusted for the injected 18F-
FDG dose and the body weight of the patient. Afterward, BAT
SUVmax were corrected by the
18F-FDG blood pool activity in
the jugular veins (JVs) in order to obtain BAT target-to-back-
ground ratios (TBRmax). For evaluation of the blood pool
activity, at least six 3 to 4-mm ROIs were placed in consecutive
slices of the JV and averaged. The individual BAT TBRmax
values obtained in each slice were then averaged to derive a
meanTBRmax for the BAT (Figure 1C).
Image Analysis of PAT, VAT, and Subcutaneous
Adipose Tissue
Image analysis was performed on a dedicated commer-
cially available workstation (Extended Brilliance Workspace
V4.5.3.40140; Philips Healthcare Nederland B.V., Eindhoven,
The Netherlands).
In order to control for the specific metabolic activity of
PAT and VAT as depicted by 18F-FDG PET, we also analyzed
the 18F-FDG uptake in subcutaneous adipose tissue (SAT),
which is known to be less metabolically active compared to
VAT.25,26 PAT, VAT, and SAT were identified based on a
predefined range of Hounsfield units (70 to 110) from CT
images as previously described.21 After fusion with the PET
images, standard ROIs (7–15 mm, depending on the adipose
tissue region) were placed on 3 consecutive slices whenever
possible and SUVmax values across those slices were averaged
(Figure 1A and B). SAT analysis was performed by placing
ROIs in the presternal SAT. PAT ROIs were placed in the
substernal mediastinal region of the chest cranial of the heart
and therefore as far away as possible from the myocardium and
the large vessels in order to exclude overspill from the myo-
cardial and/or vascular 18F-FDG uptake into the PAT region
(Figure 1A). For VAT analysis, 3 consecutive standard
ROIs were placed in the abdominal VAT above or below
the kidneys to avoid overspill from the physiological
18F-FDG uptake in the kidneys (Figure 1B). Overspill from
intestinal, muscle, and/or vascular uptake into the abdominal
adipose tissue was widely excluded by placing the ROIs at least
2 cm away from these structures. Again, SUVmax values across
those slices were averaged. In general, PAT and VAT ROIs
were not placed at all if an overspill from surrounding struc-
tures into the respective PAT or VAT region could not be
excluded to the highest possible degree. As for the BAT
SUVmax values, PAT, VAT, and SAT SUVmax were corrected
by the 18F-FDG blood pool activity in order to obtain PAT,
VAT, and SAT TBRmax values, respectively, which were
afterward averaged to derive meanTBRmax values to reflect
the true metabolic activity and/or the inflamed state of fat
tissue cells.
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Image Analysis of the Vessels
Image analysis of the vessels was performed on the same
workstation as mentioned previously. The methodology for the
analysis and the excellent reproducibility of the measurements
has been previously reported.23,24 Briefly, arterial 18F-FDG
uptake was quantified by drawing a ROI around each common
carotid artery on every slice of the coregistered transaxial PET/
CT images (Figure 2A and B). By averaging the SUVmax values
of all arterial slices of the left and right common carotid, a
meanSUVmax value was derived for the carotid arteries. The
arterial TBRmax was calculated by normalizing the SUVmax for
the 18F-FDG blood pool activity by dividing the SUVmax value
in the artery by the average blood mean SUV estimated from
both JV as described earlier. The arterial TBRmax values were
then averaged to derive a meanTBRmax for both carotid arteries.
The TBR is considered to be a reflection of arterial 18F-FDG
uptake and reflective of underlying macrophage activity.17
Statistical Analysis
All continuous variables are expressed as mean standard
deviation and categorical data as absolute numbers and percen-
tages. Normality of distribution of data was tested using the
Kolmogorov–Smirnov test. Comparisons between continuous
variables were performed with the independent or paired
samples Student t test or the Mann–Whitney U test and
correlations with the Pearson or Spearman correlation coeffi-
cient, wherever appropriate. Comparison between the groups of
patients and controls was performed using analysis of variance
with appropriate correction for multiple comparisons using
Tukey post hoc testing.
Differences between the presurgical and postsurgical
18F-FDG uptake in the carotids, the PAT, the VAT, the SAT,
the BAT, and between the presurgical and postsurgical BMI are
given as delta (D). All statistical analyses were performed using
SPSS statistical package 16.0 (SPSS Inc, Chicago, IL).
RESULTS
Population Characteristics
Characteristics of the patients as well as the healthy 7 lean
and 5 overweight volunteers are given in Table 2, and PET-
related methodological data is given in Table 1.15,19,20
BMI
The BMI showed a highly significant decrease 1 year after
BaS in the patient group (Table 2). No significant correlation
was seen between preoperative and postoperative BMI values
and all of the other respective 18F-FDG uptake values in the
TABLE 1. PET-Related Data of the Study Population and the 2 Groups of Controls
PET Data
Patients Controls
Pre surgery After surgery BMI < 25 BMI  25 < 30
n 10 7 5
Fasting glucose, mmol/L

5.19 0.32 5.13 0.37 5.03 0.49 5.3 0.4
18F-FDG dose injected, MBq

83.4 11.3 78.6 5.03 78.1 5.52 78.6 3.51
18F-FDG blood pool activity
(jugular vein, meanSUVmean)

1.10 0.32 1.28 0.57 1.18 0.47 1.43 0.12
Carotids 18F-FDG uptake
meanTBRmax
y 1.92 0.35 1.23 0.15 1.39 0.21 1.30 0.09
DCarotids meanTBRmax 0.69 0.34 (0.32 to 1.5)
PAT 18F-FDG uptake
meanTBRmax
z 1.34 0.49 0.84 0.08
DPAT meanTBRmax 0.5 0.47 (0.03 to 1.67)
VAT 18F-FDG uptake
meanTBRmax
§ 0.65 0.19 0.36 0.11
DVAT meanTBRmax 0.29 0.19 (0.03 to 0.67)
SAT 18F-FDG uptake
meanTBRmax
jj 0.54 0.3 0.44 0.21
DSAT meanTBRmax 0.1 0.15 (0.31 to 0.14)
BAT 18F-FDG uptake
TBRmax
jj 0.98 2.08 2.44 2.97
DBAT meanTBRmax 1.46 2.76 (1.5 to 7.33)
Values are meanSD or n (%). DDifference over 1 year between pre surgery and postsurgery. BAT¼ brown adipose tissue, BMI ¼ body mass
index, MBq¼megabecquerel, n.s. ¼ not significant, PAT¼ pericardial adipose tissue, PET ¼ positron emission tomography, SAT¼ subcutaneous
adipose tissue, SD ¼ standard deviation, TBR¼ target-to-background ratio, VAT¼ visceral adipose tissue.
P¼ n.s. for patients pre surgery vs patients postsurgery, patients pre surgery vs both groups of controls, patients postsurgery vs both groups of
controls, and between both groups of controls.
yP< 0.0001 for patients pre surgery vs patients postsurgery; P¼ 0.002 for patients pre surgery vs controls BMI < 25; P¼ 0.001 for patients pre
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carotids, the PAT, VAT, SAT, and the BAT, respectively
(P¼ n.s. for all). Also, no significant correlation was observed
between the DBMI and the DCarotids, DVAT, DPAT, DSAT,
and DBAT meanTBRmax, respectively (P¼ n.s. for all).
Vascular 18F-FDG Uptake
In BaS patients, carotids meanTBRmax before surgery
(Carotidspre meanTBRmax) was significantly higher compared
to the carotids meanTBRmax values in both groups of controls.
However, patient’s 18F-FDG uptake in the carotids decreased
1 year after BaS leading to a significantly lower Carotidspost
meanTBRmax compared to the respective preoperative values
(Table 1, Figure 3A). Accordingly, BaS patient’s Carotidspost
meanTBRmax 1 year after surgery were not significantly different
from the 18F-FDG uptake parameters of the carotids in the
2 groups of controls (Table 1, Figure 3B). In BaS patients, the
18F-FDG blood pool activity within the JV was not significantly
different between the presurgical and postsurgical PET (Table 1).
Additionally, there were no significant differences between
patient’s presurgical and postsurgical 18F-FDG blood pool
activity, respectively, and both groups of controls (Table 1).
PAT, VAT, and SAT 18F-FDG Uptake
The metabolic activity of PAT and VAT considerably
declined after BaS leading to a significantly lower PATpost and
VATpost meanTBRmax compared with the respective preoperative
values (Table 1, Figure 4A and B). Furthermore, a significantly
positive correlation was seen between DPAT and DVAT
meanTBRmax (r¼ 0.674, P¼ 0.033) and between DCarotids and
DVAT meanTBRmax (r¼ 0.644, P¼ 0.044). Accordingly, a
positive correlative trend between DCarotids and DPAT
meanTBRmax (r¼ 0.560, P¼ 0.093) was observed. These findings
are in contrast to the control measurements of the 18F-FDG
uptake in the SAT, which did not show a significant decline
after BaS (Table 1). Furthermore, no significant correlation was
found between DCarotids and DSAT meanTBRmax, between
DPAT and DSAT meanTBRmax, and between DVAT and DSAT
meanTBRmax, respectively (P¼ n.s. for all).
FIGURE 1. 18F-FDG PET/CT image analysis of the (A) PAT, the (B) VAT, and (C) BAT. For PATand VAT, standard ROIs (green) were placed on
3 consecutive slices whenever possible and SUVmax values across those slices were averaged. Afterward, meanSUVmax values were corrected
for the 18F-FDG uptake blood pool activity in the JVs to derive mean TBR (meanTBRmax) of the
18F-FDG uptake. PAT ROIs were placed in the
substernal mediastinal region of the chest cranial of the heart to avoid an 18F-FDG overspill from the myocardium or the thoracic
vasculature. For VAT analysis, ROIs were placed in the abdominal visceral fat tissue above or below the kidneys to avoid overspill from the
physiological 18F-FDG uptake in the kidneys. (C) Typical localization of BAT in the shoulders (arrows) 1 year after BaS. In this patient, no
BATat all was observed before BaS (image not shown). As with PATand VAT, SUVmax values of BAT were afterward corrected for blood pool
activity in the JV to derive TBRmax values.
18F-FDG ¼ 18F-fluorodeoxyglucose, BaS ¼ bariatric surgery, BAT ¼ brown adipose tissue,
JV ¼ jugular vein, PAT ¼ pericardial adipose tissue, PET/CT ¼ positron emission tomography/computed tomography, ROI ¼ region of
interest, SUVmax ¼ maximal standardized uptake value, TBR ¼ target-to-background ratio, VAT ¼ visceral adipose tissue.
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No significant correlations were found between the
meanTBRmax values in VAT and PAT as well as between any
of the meanTBRmax values in the 3 adipose tissues and in the
carotids preoperatively and postoperatively (P¼ n.s. for all).
However, we found a significant correlation between the pre-
operative meanTBRmax values in the SAT and the respective
meanTBRmax values in VAT (r¼ 0.632, P¼ 0.05) and PAT
(r¼ 0.786, P¼ 0.007), respectively. In contrast, no significant
correlation was found between the postoperative SAT
meanTBRmax and the VAT and PAT meanTBRmax, respectively
(P¼ n.s.).
BAT Activity
Results regarding the BAT activity before and 1 year after
BaS in the present patient population were previously published
by our group.19,20 Briefly, before surgery, a minimal cold-
induced BAT activity in supraclavicular depots was observed
in 2 females.20 After BaS, BAT was seen in 5 of 10 subjects,
including the 2 mentioned female subjects. Of these 5 BAT-
positive patients, 1 subject was observed with an increased BAT
activity, 3 previously BAT-negative subjects became BAT
positive after surgery, and 1 subject showed a decreased
BAT activity.20
We found a negative correlation between DPAT and
DBAT meanTBRmax (r¼0.755, P¼ 0.012). A negative
trend was observed between the DCarotids and the DBAT
meanTBRmax (r¼0.239, P¼ 0.506) and between DVAT and
DBAT meanTBRmax (r¼0.593, P¼ 0.071). No significant
correlation was found between the DSAT and DBAT
meanTBRmax (P¼ n.s.).
No significant correlations were seen between the pre-
operative and postoperative meanTBRmax values of VAT, PAT,
and SAT and the respective preoperative and postoperative
BAT meanTBRmax values (P¼ n.s. for all). Also, correlations
between the preoperative and postoperative meanTBRmax values
in the carotids and the respective BAT meanTBRmax values failed
to show statistical significance (P¼ n.s. for all).
DISCUSSION
One year after BaS, 18F-FDG uptake in carotid arteries was
dramatically decreased reflecting a reduction in carotid artery
inflammation. In addition, 18F-FDG uptake in PAT and VAT
significantly declined after BaS and, with regard to VAT, also
showed a significant correlation with the diminished carotid
wall inflammation. As was previously published by our group,
BAT activity increased over the same time period.19,20 The
FIGURE 2. 18F-FDG PET/CT image analysis of the carotid arteries (arrows) before and after BaS. 18F-FDG PET/CT images of the neck in
transaxial and coronal view (A) before and (B) after BaS. ROIs (green) drawn around the outer border of the vessel wall of the right
common carotid artery (SUVmax, SUVmean, and diameter of the ROIs) showing higher
18F-FDG uptake values before BaS (SUVmax 2.3 vs
SUVmax 1.1 after BaS). SUVmax values were corrected for the blood pool activity in the JVs to derive mean TBR (meanTBRmax) values.
18F-FDG
¼ 18F-fluorodeoxyglucose, BaS ¼ bariatric surgery, JV ¼ jugular vein, PET/CT ¼ positron emission tomography/computed tomography,
ROI ¼ region of interest, SUVmax ¼ maximal standardized uptake value, TBR ¼ target-to-background ratio.
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results of our study indicate a significant benefit within 1 year
after BaS with regard to the degree of vascular inflammation
and the metabolic activity in different adipose tissues. We
hypothesize that these might contribute to the previously
reported diminished cardiovascular risk in morbidly obese
patients after BaS.2,5,7–9
Impressively, our study showed that the decrease in carotid
inflammation could already be observed 1 year after BaS in
otherwise healthy patients, indicating that vascular inflammation
as part of atherosclerosis in obesity is reversible. Additionally,
patients’ declining carotid 18F-FDG uptake reached even values
comparable to normal weight subjects with a BMI < 25.
The SOS study showed that cardiovascular risk factor
improvement requires a sustained and very large (10–40 kg)
weight loss.2,5 Accordingly, a mean weight loss of 36.5 kg was
seen in our patient population 1 year after BaS, which might at
least partly explain the highly significant decrease of the
inflammatory changes in the carotids. However, in the surgery
group of the SOS study, no significant association between
weight loss and cardiovascular events could be detected.2,5 This
is in accordance with the results of our study as we also failed to
show any significant impact of BMI or DBMI on not only the
degree of carotid inflammation but also on the metabolic
activity in VAT, PAT, and BAT. Since there was a rather fast
and impressive decline of carotid artery inflammation without a
direct correlation with the degree of weight loss, our findings
indicate a potential weight loss independent effect of BaS. In
line with this finding, it was previously observed that the
relative expression and serum levels of interleukin-6 (IL-6),
tumor necrosis factor (TNF-a), or C-reactive protein (CRP)
were reduced 1 year after BaS but did not correlate with weight,
BMI, and body fat.5,27,28 We speculate that this effect might be
related to ‘‘direct’’ anti-inflammatory effects of BaS as recently
described.27,28
As with the diminished carotid inflammation, the 18F-FDG
uptake both in PAT and VAT significantly declined 1 year after
BaS. The rationale for analyzing the metabolic activity in VATs
by means of 18F-FDG PET was related to the fact that volu-
metric measurements with CT or magnetic resonance imaging
alone may not be sufficient and could be improved by using
functional imaging with PET to determine the metabolic
activity in fat tissue and its relation to the cardiovascular
risk.11,12,21,29 Furthermore, it is now well established that
VAT is functionally more active than SAT and that its expan-
sion, rather than that of SAT, confers a high risk for developing
the metabolic syndrome as well as an increased incident of
cardiovascular disease.25,26 These differences might explain the
higher 18F-FDG uptake values in VAT than SAT in our study.21
In accordance, we did not find neither a significant decline of
the metabolic activity of SAT 1 year after BaS nor any
correlation between the decline of the 18F-FDG uptake in the
carotids, in the PAT, and in the VAT and the increase of the
metabolic activity of the BAT on the one hand and the delta of
the SAT on the other hand. However, the underlying mechan-
isms are still not completely understood. In contrast, monocytes
and monocyte-derived macrophages are well known to be the
cellular hallmarks in the pathogenesis of atherosclerosis.30
These macrophages seem also to play a significant role in
inflammatory changes of adipose tissues. Animal studies
demonstrated a specific contribution of certain monocyte sub-
sets to atherogenesis and, additionally, an obesity-associated
macrophage accumulation in adipose tissue.31–34 As it is known
that the 18F-FDG uptake reveals a highly significant correlation
with the degree of macrophage density in the arterial wall as
depicted by histological CD 68 staining, it is not unlikely that
18F-FDG uptake in adipose tissue is also attributed to the
macrophage density of adipose tissues.17 Therefore, our study
seems to further support potentially inflammatory changes of
TABLE 2. Characteristics of the Study Population and the 2 Groups of Controls
Characteristics
Patients Controls
Pre surgery After Surgery BMI < 25 BMI  25 < 30
n 10 7 5
Age, y

40 9 41 9 25 4 26 4
Sex
Male 2 (20.0) 2 (20.0) 6 (85.7) 5 (100)
Female 8 (80.0) 8 (80.0) 1 (14.3) 0 (0)
Weight, kgy 127.3 17.5 (98.2–155.0) 90.8 16.5 (74.0–120.0) 77.6 7.2 (70.3–90.3) 91.5 4.7 (85.6–95.5)
Height, mz 1.75 0.09 (1.63–1.91) 1.75 0.09 (1.63–1.91) 1.83 0.06 (1.77–1.92) 1.84 0.02 (1.82–1.88)
BMI§, kg/m2 41.7 4.34 (34.3–48.4) 29.7 4.15 (24.3–35.9) 23.2 1.20 (21.3–24.4) 27.1 1.25 (25.9–28.6)
<25 0 1 (10.0) 7 (100) 0
25 < 30 0 3 (30.0) 0 5 (100)
30 10 (100) 6 (60.0) 0 0
DBMI 12.0 3.0 (7.2 to 15.6)
Values are meanSD or n (%). DDifference over 1 year between pre surgery and postsurgery. BMI¼ body mass index, n.s.¼ not significant, SD¼
standard deviation.
P¼ 0.001 for patients pre surgery vs controls BMI< 25, and P¼ 0.003 for patients pre surgery vs controls BMI 25< 30; P< 0.0001 for patients
postsurgery vs controls BMI < 25, and P¼ 0.002 for patients postsurgery vs controls BMI  25 < 30.
yP< 0.0001 for patients pre surgery vs patients postsurgery, for patients pre surgery vs controls BMI< 25, and for patients pre surgery vs controls
BMI  25 < 30; P¼ n.s. for patients postsurgery vs both groups of controls, and between both groups of controls.
zP¼ n.s. for patients vs both groups of controls, and between both groups of controls.
§ P< 0.0001 for patients pre surgery vs patients postsurgery, for patients pre surgery vs controls BMI< 25, and for patients pre surgery vs controls
BMI  25 < 30; P¼ 0.001 for patients postsurgery vs controls BMI < 25; P¼ n.s. for patients postsurgery vs controls BMI  25 < 30 and between
both groups of controls.
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adipose tissues underlying the metabolic activity in PAT and
VAT as depicted by the 18F-FDG uptake.
Our study revealed interesting clues on the role of BAT on
inflammatory changes in the carotid arteries 1 year after BaS.
There is emerging evidence that activation of BAT increases
energy expenditure and that obese and overweight subjects have
lower BAT activity.13,15,16,19,20 Moreover, animal studies and
more recent clinical evidence argue that decreasing adiposity by
activating BAT and potently oxidizing fatty acids would, in
most settings, indirectly benefit the vasculature.16,25,35 In fact,
in humans, cervical BAT size is negatively correlated with BMI
and the degree of coronary atherosclerosis.35 BAT has therefore
emerged as an attractive target for the treatment of obesity and
associated cardiovascular disease.16 In the current study, we
observed a negative trend between the decline of carotid wall
inflammation and the increase of BAT activity 1 year after BaS.
It could thus be hypothesized that increasing BAT activity leads
to an anti-inflammatory effect in the vasculature, as depicted by
the decreasing 18F-FDG uptake in the carotids. A fact, which
might further elucidate the anti-inflammatory properties of
BAT, is the significant association between the decline of
the metabolic activity of PAT with the increase in BAT activity,
which we observed after BaS. This might be explained by
declining inflammatory changes in PAT due to the observed
increase of BAT activity. This effect was previously described
in an animal model with BAT-transplanted mice.36
FIGURE 3. (A) Vascular 18F-FDG uptake in the carotids in patients
before and 1 year after BaS. (B) Comparison of the preoperative
and postoperative vascular 18F-FDG uptake between patients and
the 2 groups of controls. Arterial 18F-FDG uptake in the carotids
(meanTBRmax) significantly decreased 1 year after BaS (A). Patients’
preoperative 18FDG uptake in the carotids was significantly higher
as compared to lean (BMI < 25; P¼0.002) and overweight
controls (BMI  25 < 30; P¼0.001). One year after BaS, no
significant differences between patients’ carotids meanTBRmax
compared with both groups of controls can be observed (B).
18F-FDG ¼ 18F-fluorodeoxyglucose, BaS ¼ bariatric surgery,
BMI ¼ body mass index, TBR ¼ target-to-background ratio.
FIGURE 4. Comparison between the (A) PAT and the abdominal
(B) VAT 18F-FDG uptake of the patients before and 1 year after BaS.
Both PAT and VAT meanTBRmax shows a highly significant decline
over a time period of 1 year after BaS. 18F-FDG ¼ 18F-fluorodeox-
yglucose, BaS ¼ bariatric surgery, BMI ¼ body mass index,
PAT ¼ pericardial adipose tissue, TBR ¼ target-to-background
ratio, VAT ¼ visceral adipose tissue.
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Although some might argue that the limited number of
patients in our study could hamper interpretation, we believe the
number of patients to be sufficient because of the depth of our
investigations combined with the fact that every person has been
his/her own control. As we only included healthy patients and
excluded all patients with any kind of comorbidities, only a
limited number of patients was feasible for inclusion. This was
mainly due to the fact that most of patients in question for
inclusion suffered from diabetic or prediabetic disease. Further-
more, the patients group consisted of more females and much
older subjects compared with the 2 groups of controls. Again,
because every person has been his/her own control and the
differences were the same before and after BaS, age and/or
gender-related bias is unlikely.
As we applied an imaging protocol including cold stimu-
lation appropriate to disclose BAT activity,15,19,20 we could not
take advantage of methods that have been employed to optimize
the arterial 18F-FDG signal, for example, a longer 18F-FDG
circulation time. However, the same imaging protocol was
applied to the subjects in all groups. Furthermore, we, because
of restrictions due to radiation protection of the patients, were
not able to apply a weight-adapted FDG dose. Instead we chose
a standard dose of the tracer. However, previously published
data indicated no significant impact of the injected FDG dose on
the degree of FDG uptake in the vasculature. In addition, we
used TBR with for the underlying blood pool corrected SUV
values of the carotids.37 Therefore, the impact of the low FDG
standard dose in the current study should not lead to a signifi-
cant impact on our study results.
Obviously, we were not able to retain biopsies to compare
histology of vascular and adipose tissues with the imaging
parameters and have, with that regard, to rely on previously
published data.21,34
Intentionally, we decided not to evaluate biomarkers in the
patient group because of the known fact that inflammatory
biomarkers such as CRP, IL-6, or TNF-a show significant,
weight-independent reductions after BaS.5,27,28 Therefore,
repetitive evaluation of the biomarkers within the context of
the current study would not have added any significant new
information with that regard.
We demonstrated that in morbidly obese patients, the
degree of carotid inflammation normalizes already 1 year after
BaS. This is intriguing as our results indicate that vascular
inflammation as part of the atherosclerotic disease process may
be almost completely reversed, even within that rather short
time period. This effect appeared not to be completely related to
only the degree of weight loss per se and, intriguingly, one
might speculate on anti-inflammatory effects induced by BaS
itself. In addition, a significantly reduced metabolic activity of
PAT and VAT as well as an increased degree of BAT was
observed 1 year after BaS. We hypothesize the latter to possibly
have contributed to the observed beneficial changes in vascular
inflammation and the metabolic activity in PAT and VAT.
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2. Sjöström L, Lindroos AK, Peltonen M, et al., Swedish Obese
Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovas-
cular risk factors 10 years after bariatric surgery. N Engl J Med.
2004;351:2683–2693.
3. James WP, Caterson ID, Coutinho W, et al., SCOUT Investigators.
Effect of sibutramine on cardiovascular outcomes in overweight and
obese subjects. N Engl J Med. 2010;363:905–917.
4. Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev
Nutr. 2001;21:323–341.
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